EBITDA: Income before interest, taxes, depreciation and amortization.
enVVeno Medical Corporation (NVNO) had EBITDA of $-3.90M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.74M |
|
-- |
|
-- |
|
$4.01M |
|
$-4.01M |
|
$0.28M |
|
$-3.74M |
|
$-3.74M |
|
$-3.74M |
|
$-3.74M |
|
$-3.74M |
|
$-3.74M |
|
$-4.01M |
|
|
EBITDA |
$-3.90M |
0.59M |
|
0.59M |
|
$-5.69 |
|
$-5.69 |
|
| Balance Sheet Financials | |
$28.83M |
|
$0.05M |
|
$0.74M |
|
$29.56M |
|
$2.12M |
|
-- |
|
$0.31M |
|
$2.43M |
|
$27.13M |
|
$27.13M |
|
$27.13M |
|
0.66M |
|
| Cash Flow Statement Financials | |
$-15.57M |
|
$15.86M |
|
$1.02M |
|
$1.75M |
|
$3.06M |
|
$1.31M |
|
$3.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.77% |
|
-13.77% |
|
-12.64% |
|
-13.77% |
|
$41.36 |
|
$-26.44 |
|
$-26.43 |
|